Acute Aortic Dissection: Observational Lessons Learned From 11 000 Patients
BACKGROUND: Over the past 25 years, diagnosis and therapy for acute aortic dissection (AAD) have evolved. We aimed to study the effects of these iterative changes in care. METHODS: Patients with nontraumatic AAD enrolled in the International Registry of Acute Aortic Dissection (61 centers; 15 countries) were divided into time-based tertiles (groups) from 1996 to 2022. The impact of changes in diagnostics, therapeutic care, and in-hospital and 3-year mortality was assessed. Cochran-Armitage trend and Jonckheere-Terpstra tests were conducted to test for any temporal trend. RESULTS: Each group consisted of 3785 patients (mean age, ≈62 years old; ≈65.5% males); nearly two-thirds had type A AAD. Over time, the rates of hypertension increased from 77.8% to 80.4% ( P =0.002), while smoking (34.1% to 30.6%, P =0.033) and atherosclerosis decreased (25.6%–16.6%; P <0.001). Across groups, the percentage of surgical repair of type A AAD increased from 89.1% to 92.5% ( P <0.001) and was associated with decreased hospital mortality (from 24.1% in group 1 to 16.7% in group 3; P <0.001). There was no difference in 3-year survival ( P =0.296). For type B AAD, stent graft therapy (thoracic endovascular aortic repair) was used more frequently (22.3%–35.9%; P <0.001), with a corresponding decrease in open surgery. Endovascular in-hospital mortality decreased from 9.9% to 6.2% ( P =0.003). As seen with the type A AAD cohort, overall 3-year mortality for patients with type B AAD was consistent over time ( P =0.084). CONCLUSIONS: Over 25 years, substantial improvements in-hospital survival were associated with a more aggressive surgical approach for patients with type A AAD. Open surgery has been partially supplanted by thoracic endovascular aortic repair for complicated type B AAD, and in-hospital mortality has decreased over the time period studied. Postdischarge survival for up to 3 years was similar over time.
Authors
- Chih-Wen Pai (ORCID: https://orcid.org/0000-0003-0983-5947)
- Eric M. Isselbacher (ORCID: https://orcid.org/0000-0003-0393-168X)
- Truls Myrmel (ORCID: https://orcid.org/0000-0002-4148-9223)
- Daniel Montgomery (ORCID: https://orcid.org/0000-0002-4570-1391)
- Marco Di Eusanio (ORCID: https://orcid.org/0000-0002-0991-3960)
- Derek R. Brinster
- Dan Gilon (ORCID: https://orcid.org/0000-0002-7861-1202)
- Santi Trimarchi (ORCID: https://orcid.org/0000-0001-5996-3264)
- Marek Ehrlich (ORCID: https://orcid.org/0000-0002-1114-5788)
- Eduardo Bossone (ORCID: https://orcid.org/0000-0003-2769-9950)
- Arturo Evangelista (ORCID: https://orcid.org/0000-0001-8182-1174)
- Christoph Nienaber (ORCID: https://orcid.org/0000-0001-9671-8030)
- Reed E. Pyeritz (ORCID: https://orcid.org/0000-0002-3288-1442)
- Kim A. Eagle (ORCID: https://orcid.org/0000-0003-0031-0191)
- Thomas G. Gleason (ORCID: https://orcid.org/0000-0001-5858-6073)
- Himanshu J. Patel (ORCID: https://orcid.org/0000-0001-7639-2416)
- Kevin Harris (ORCID: https://orcid.org/0000-0002-5793-0036)
- Alan C. Braverman (ORCID: https://orcid.org/0000-0003-1859-310X)
Institutions
- University Hospital of North Norway (NO)
- Northwell Health (US)
- Mission Health (US)
- Washington University in St. Louis (US)
- Cardiovascular Institute of the South (US)
- University of Michigan (US)
- Hadassah Medical Center (IL)
- Royal Brompton & Harefield NHS Foundation Trust (GB)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Massachusetts General Hospital (US)
- Michigan Medicine (US)
- Federico II University Hospital (IT)
- Vall d'Hebron Hospital Universitari (ES)
- Minneapolis Heart Institute Foundation (US)
- Medical University of Vienna (AT)
- University of Pennsylvania (US)
Publication Details
- Journal
- Circulation Cardiovascular Quality and Outcomes
- Published
- 2024-08-15
- DOI
- https://doi.org/10.1161/circoutcomes.123.010673
- Citations
- 13
- Primary Topic
- Aortic Disease and Treatment Approaches
- Type
- article
- Field-Weighted Citation Impact
- 5.45